Urocortins in heart failure and ischemic heart disease

International Journal of Cardiology
Phitsanu BoonprasertNipon Chattipakorn

Abstract

Urocortins, a novel member of the corticotrophin-releasing factor (CRF) family, have been shown in animal and human studies to possess several beneficial effects in stress, cardiovascular and renal function, and inflammatory responses via CRF receptors. In the heart, urocortins have been demonstrated to produce cardioprotective effects during ischemia and reperfusion injury. Urocortins have also exerted effects on hemodynamic, endocrine and renal parameters in experimental animal heart failure models. In humans, plasma urocortin levels have been shown to significantly increase in systolic heart failure patients. This growing evidence suggests that urocortins may have a prognostic value as well as being a potential therapeutic treatment for heart failure and myocardial infarction patients. Currently, only a few clinical studies on urocortins are available. In this review article, the role of urocortins in the heart has been summarized. Their possible beneficial roles in heart failure and myocardial infarction have been discussed, based on relevant published articles from both basic and clinical studies available to date.

References

Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R ChenW W Vale
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·T W LovenbergT Oltersdorf
May 1, 1996·Endocrinology·C J DonaldsonW W Vale
Oct 1, 1996·The Journal of Clinical Endocrinology and Metabolism·F PetragliaW Vale
Jan 3, 1997·Clinica Chimica Acta; International Journal of Clinical Chemistry·J Mair
Jun 25, 1998·Neuropeptides·A OkosiR A Knight
May 26, 1999·Clinical Endocrinology·K IinoH Nagura
Jan 12, 2000·Molecular and Cellular Endocrinology·B K BrarD S Latchman
Mar 18, 2000·The Journal of Biological Chemistry·B K BrarD S Latchman
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·T M ReyesP E Sawchenko
Mar 16, 2001·The Journal of Endocrinology·K TeruiT Suda
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·K LewisW W Vale
Oct 13, 2001·Trends in Cardiovascular Medicine·D S Latchman
Dec 12, 2001·The Journal of Endocrinology·B J HolmbergD H Keisler
Jan 15, 2002·The Journal of Clinical Endocrinology and Metabolism·Yuichiro KimuraHironobu Sasano
Jul 10, 2002·Journal of the American College of Cardiology·Tiziano M ScarabelliDavid S Latchman
Sep 18, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Daniel SchulmanDerek M Yellon
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Jennifer M GordonRebecca H Ritchie
Apr 16, 2003·European Journal of Pharmacology·Aly M Abdelrahman, Catherine C Y Pang
Jun 5, 2003·European Journal of Pharmacology·Kenneth B MackayAlan C Foster
Dec 4, 2003·Clinical Science·Leong L NgJoan E Davies
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Janette SeresMonika Ehrhart-Bornstein
Mar 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Mark E DavisA Mark Richards
Apr 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Kazuhiro TakahashiShigeki Shibahara
Aug 24, 2004·Current Medicinal Chemistry. Cardiovascular and Hematological Agents·Tiziano Scarabelli, Richard Knight
Aug 24, 2004·Current Medicinal Chemistry. Cardiovascular and Hematological Agents·Christopher J CharlesA Mark Richards
Sep 11, 2004·Biochemical and Biophysical Research Communications·Kevin M LawrenceDavid S Latchman
Jul 29, 2005·Canadian Journal of Physiology and Pharmacology·Chun-Na LiuShengnan Li
Mar 1, 2006·Current Problems in Cardiology·Tiziano M ScarabelliJagat Narula
Jul 11, 2006·European Heart Journal·Miriam T RademakerA Mark Richards

❮ Previous
Next ❯

Citations

May 23, 2009·Cardiovascular Research·Eva Calderón-SanchezTarik Smani
Feb 28, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yehezkel SztainbergAlon Chen
May 14, 2010·Future Cardiology·Jonathan R Dalzell, Colette E Jackson
Jun 22, 2011·Journal of Molecular and Cellular Cardiology·Theophilus I EmetoJonathan Golledge
Jun 15, 2011·Cell Calcium·Eva María Calderón-SánchezAntonio Ordóñez
Mar 4, 2009·Regulatory Peptides·Kazunori KageyamaToshihiro Suda
Sep 6, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Si ChenJi Li
Feb 22, 2012·British Journal of Pharmacology·K PatelA M Richards
Jul 20, 2010·European Journal of Clinical Investigation·Arintaya PhrommintikulNipon Chattipakorn
Apr 7, 2010·Biochemical Pharmacology·Sowmya VenkatasubramanianNinian N Lang
May 23, 2015·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Il Young YouSei Jin Youn
Jun 24, 2011·Journal of Cardiovascular Pharmacology·Christopher J CharlesA Mark Richards
Jun 12, 2009·Critical Reviews in Clinical Laboratory Sciences·Aldo ClericoMichele Emdin
Apr 25, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis